AU2005261687B8 - Combination therapy for the prevention or treatment of Alzheimer's disease as well as kit therefor - Google Patents
Combination therapy for the prevention or treatment of Alzheimer's disease as well as kit therefor Download PDFInfo
- Publication number
- AU2005261687B8 AU2005261687B8 AU2005261687A AU2005261687A AU2005261687B8 AU 2005261687 B8 AU2005261687 B8 AU 2005261687B8 AU 2005261687 A AU2005261687 A AU 2005261687A AU 2005261687 A AU2005261687 A AU 2005261687A AU 2005261687 B8 AU2005261687 B8 AU 2005261687B8
- Authority
- AU
- Australia
- Prior art keywords
- app
- binding
- kit according
- amino acid
- amyloid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0007—Nervous system antigens; Prions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6056—Antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Psychiatry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT0118504A AT500483B1 (de) | 2004-07-13 | 2004-07-13 | Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung |
| ATA1185/2004 | 2004-07-13 | ||
| PCT/EP2005/053224 WO2006005706A2 (de) | 2004-07-13 | 2005-07-06 | Kombinationstherapie zur vorbeugung oder behandlung der alzheimer´schen erkrankung sowie kit hierfür |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| AU2005261687A1 AU2005261687A1 (en) | 2006-01-19 |
| AU2005261687B2 AU2005261687B2 (en) | 2011-02-17 |
| AU2005261687B8 true AU2005261687B8 (en) | 2011-07-21 |
Family
ID=35115768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2005261687A Ceased AU2005261687B8 (en) | 2004-07-13 | 2005-07-06 | Combination therapy for the prevention or treatment of Alzheimer's disease as well as kit therefor |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US7935348B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1765388B8 (cg-RX-API-DMAC7.html) |
| JP (2) | JP5642333B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101158600B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN101022825B (cg-RX-API-DMAC7.html) |
| AT (1) | AT500483B1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2005261687B8 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2577332C (cg-RX-API-DMAC7.html) |
| DK (1) | DK1765388T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2414872T3 (cg-RX-API-DMAC7.html) |
| PL (1) | PL1765388T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT1765388E (cg-RX-API-DMAC7.html) |
| TW (1) | TW200602072A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006005706A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003303198A1 (en) | 2002-12-19 | 2004-07-14 | New York University | Method for treating amyloid disease |
| DE10303974A1 (de) | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung |
| AT500483B1 (de) * | 2004-07-13 | 2006-01-15 | Mattner Frank Dr | Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung |
| RU2442793C2 (ru) | 2005-11-30 | 2012-02-20 | Эбботт Лэборетриз | АНТИТЕЛА ПРОТИВ ГЛОБУЛОМЕРА Аβ, ИХ АНТИГЕНСВЯЗЫВАЮЩИЕ ЧАСТИ, СООТВЕТСТВУЮЩИЕ ГИБРИДОМЫ, НУКЛЕИНОВЫЕ КИСЛОТЫ, ВЕКТОРЫ, КЛЕТКИ-ХОЗЯЕВА, СПОСОБЫ ПОЛУЧЕНИЯ УКАЗАННЫХ АНТИТЕЛ, КОМПОЗИЦИИ, СОДЕРЖАЩИЕ УКАЗАННЫЕ АНТИТЕЛА, ПРИМЕНЕНИЯ УКАЗАННЫХ АНТИТЕЛ И СПОСОБЫ ИСПОЛЬЗОВАНИЯ УКАЗАННЫХ АНТИТЕЛ |
| PL1976877T5 (pl) | 2005-11-30 | 2017-09-29 | Abbvie Inc | Przeciwciała monoklonalne przeciwko białku amyloidu beta oraz ich zastosowania |
| US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
| AU2007336770A1 (en) * | 2006-12-22 | 2008-07-03 | Genentech, Inc. | DR6 antibodies inhibiting the binding of DR6 to APP, and uses thereof in treating neurological disorders |
| US8895004B2 (en) * | 2007-02-27 | 2014-11-25 | AbbVie Deutschland GmbH & Co. KG | Method for the treatment of amyloidoses |
| WO2009054537A1 (ja) * | 2007-10-25 | 2009-04-30 | Kagoshima University | アミロイドβペプチドのミミック分子を用いたペプチドワクチン |
| ES2332846B1 (es) | 2007-10-26 | 2010-07-08 | Grifols, S.A. | Utilizacion de albumina humana terapeutica para la preparacion de un medicamento para el tratamiento de pacientes afectados por desordenes cognitivos. |
| AT506819B1 (de) * | 2008-06-12 | 2011-06-15 | Affiris Forschungs Und Entwicklungs Gmbh | Vakzin zur behandlung von alzheimer-krankheit |
| AT506820B1 (de) * | 2008-06-12 | 2011-07-15 | Affiris Forschungs Und Entwicklungs Gmbh | Vakzine gegen alzheimer-krankheit |
| US20100030196A1 (en) * | 2008-07-29 | 2010-02-04 | Medtronic, Inc. | Apheresis of a target molecule from cerebrospinal fluid |
| CN102271669A (zh) * | 2008-11-13 | 2011-12-07 | 基因改造有限责任公司 | 非大脑组织中β-淀粉样肽负载的改性 |
| CN102264411B (zh) | 2008-12-22 | 2014-10-22 | 学校法人藤田学园 | Aβ除去材料、Aβ除去器和Aβ除去系统 |
| US20110033463A1 (en) * | 2009-08-06 | 2011-02-10 | Medtronic, Inc. | Apheresis, administration of agent, or combination thereof |
| WO2011130377A2 (en) | 2010-04-15 | 2011-10-20 | Abbott Laboratories | Amyloid-beta binding proteins |
| JP5843345B2 (ja) | 2010-07-08 | 2016-01-13 | 旭化成メディカル株式会社 | β−アミロイド除去システム |
| US9062101B2 (en) | 2010-08-14 | 2015-06-23 | AbbVie Deutschland GmbH & Co. KG | Amyloid-beta binding proteins |
| US20120328605A1 (en) * | 2010-10-27 | 2012-12-27 | Daniel Larocque | Compositions and uses |
| RS53496B1 (sr) | 2011-10-04 | 2015-02-27 | Affiris Ag | POSTUPAK ZA DETEKCIJU Aβ-SPECIFIČNIH ANTITELA U BIOLOŠKOM UZORKU |
| MX352749B (es) | 2011-11-01 | 2017-12-06 | Modgene Llc | Composiciones y metodos para la reduccion de la carga amiloide-beta. |
| CN110133300B (zh) * | 2012-03-18 | 2022-02-25 | 镜株式会社 | 疾病样品分析装置、分析系统及分析方法 |
| DE102012108598A1 (de) * | 2012-09-14 | 2014-04-10 | Forschungszentrum Jülich GmbH | Neue, von D3 abgeleitete D-enantiomere Peptide und deren Verwendung |
| JP2015518474A (ja) * | 2012-04-05 | 2015-07-02 | フォルシュングスツェントルム ユーリッヒ ゲゼルシャフト ミット ベシュレンクテル ハフツングForschungszentrum Juelich GmbH | 血液、血液生産物及び器官を処置する方法 |
| CN104380111B (zh) | 2012-04-05 | 2017-08-29 | 于利希研究中心有限公司 | 包含多价结合淀粉样β蛋白的D‑肽的聚合物及其应用 |
| KR101416954B1 (ko) * | 2012-09-12 | 2014-07-16 | 한양대학교 산학협력단 | 조혈세포 분화 유도 방법 |
| CN106103467B (zh) * | 2014-03-11 | 2019-12-31 | 艾克斯-马赛大学 | 与细胞膜神经节苷脂相互作用的嵌合肽 |
| CN106466298A (zh) * | 2015-08-14 | 2017-03-01 | 上海交通大学医学院 | 一种单唾液酸四己糖神经节苷脂修饰的重组脂蛋白及其应用 |
| CN109414482A (zh) * | 2016-05-12 | 2019-03-01 | 俄亥俄州创新基金会 | 用于治疗神经退行性疾病的肽和方法 |
| US20200164008A1 (en) * | 2017-07-17 | 2020-05-28 | Spark Therapeutics, Inc. | Apheresis methods and uses |
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| KR20210124308A (ko) | 2019-01-30 | 2021-10-14 | 트루바인딩 아이엔씨. | 항-gal3 항체 및 이의 용도 |
| MX2022014786A (es) | 2020-05-26 | 2023-01-16 | Truebinding Inc | Metodos para tratar enfermedades inflamatorias mediante el bloqueo de galectina-3. |
| CN115957324A (zh) * | 2021-10-12 | 2023-04-14 | 首都医科大学宣武医院 | 外周CLU作为靶点在降低脑Aβ中的应用 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004056318A2 (en) * | 2002-12-19 | 2004-07-08 | New York University | Method for treating amyloid disease |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5476715A (en) | 1989-10-03 | 1995-12-19 | Fresenius Ag | Particulate adsorbent for the removal of biomacromolecules such as LDL and endotoxins from whole blood in extracorporeal circuits |
| AU691297B2 (en) | 1994-05-13 | 1998-05-14 | Miltenyi Biotec Gmbh | Sterile and pyrogen-free columns coupled to protein for binding and removal of substances from blood |
| EP0886085B1 (en) | 1997-06-18 | 2002-04-03 | Morse Tec Europe S.p.A. | Sprocket wheel with improved tooth profile for greater silentness |
| US7964192B1 (en) | 1997-12-02 | 2011-06-21 | Janssen Alzheimer Immunotherapy | Prevention and treatment of amyloidgenic disease |
| JP2002533169A (ja) | 1998-12-29 | 2002-10-08 | オキュロジックス コーポレイション | レオロジー的処置方法および関連するアフェレーシスシステム |
| PE20020574A1 (es) * | 2000-12-06 | 2002-07-02 | Wyeth Corp | Anticuerpos humanizados que reconocen el peptido amiloideo beta |
| DE60217107T2 (de) | 2001-06-20 | 2007-08-23 | Ramot At Tel Aviv University Ltd. | Mehrantigenisches peptid enthaltend mehrere kopien eines epitopes von einem ablagerungsformenden polypeptid und dessen verwendung |
| US20050227941A1 (en) * | 2001-12-17 | 2005-10-13 | Karen Duff | Sequestration of ass in the periphery in the absence of immunomodulating agent as a therapeutic approach for the treatment or prevention of beta-amyloid related diseases |
| WO2004013172A2 (en) | 2002-07-24 | 2004-02-12 | Innogenetics N.V. | Fragments of beta-amyloid as targets for vaccination against alzheimer disease |
| AT413945B (de) * | 2003-01-14 | 2006-07-15 | Mattner Frank Dr | Impfstoff für die alzheimer-krankheit |
| KR20050118669A (ko) * | 2003-02-01 | 2005-12-19 | 뉴랄랩 리미티드 | 가용성 a-베타에 대한 항체를 생성하기 위한 능동 면역화 |
| AT413336B (de) * | 2003-09-12 | 2006-02-15 | Mattner Frank Dr | Apherese-vorrichtung |
| US20050158306A1 (en) * | 2004-01-16 | 2005-07-21 | Halikas James A. | Treatment for neuro-degenerative disease by a blood cleansing system using monoclonal antibodies |
| AT500483B1 (de) * | 2004-07-13 | 2006-01-15 | Mattner Frank Dr | Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung |
| AT413946B (de) * | 2004-07-13 | 2006-07-15 | Mattner Frank Dr | Impfstoff gegen die alzheimer-krankheit |
| AT500835B1 (de) * | 2004-09-13 | 2007-12-15 | Affiris Forschungs & Entwicklungs Gmbh | Cholinestertransport-protein-mimotop als atherosklerose-medikament |
-
2004
- 2004-07-13 AT AT0118504A patent/AT500483B1/de not_active IP Right Cessation
-
2005
- 2005-06-17 TW TW094120199A patent/TW200602072A/zh not_active IP Right Cessation
- 2005-07-06 US US11/571,970 patent/US7935348B2/en not_active Expired - Fee Related
- 2005-07-06 PL PL05767978T patent/PL1765388T3/pl unknown
- 2005-07-06 JP JP2007520813A patent/JP5642333B2/ja not_active Expired - Fee Related
- 2005-07-06 EP EP05767978.9A patent/EP1765388B8/de not_active Expired - Lifetime
- 2005-07-06 PT PT57679789T patent/PT1765388E/pt unknown
- 2005-07-06 CA CA2577332A patent/CA2577332C/en not_active Expired - Fee Related
- 2005-07-06 DK DK05767978.9T patent/DK1765388T3/da active
- 2005-07-06 KR KR1020077002208A patent/KR101158600B1/ko not_active Expired - Fee Related
- 2005-07-06 CN CN200580023830.5A patent/CN101022825B/zh not_active Expired - Fee Related
- 2005-07-06 ES ES05767978T patent/ES2414872T3/es not_active Expired - Lifetime
- 2005-07-06 AU AU2005261687A patent/AU2005261687B8/en not_active Ceased
- 2005-07-06 WO PCT/EP2005/053224 patent/WO2006005706A2/de not_active Ceased
-
2011
- 2011-03-11 US US13/045,967 patent/US20110201987A1/en not_active Abandoned
-
2013
- 2013-01-24 JP JP2013010868A patent/JP2013116903A/ja active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004056318A2 (en) * | 2002-12-19 | 2004-07-08 | New York University | Method for treating amyloid disease |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2008506665A (ja) | 2008-03-06 |
| DK1765388T3 (da) | 2013-07-22 |
| US20080051690A1 (en) | 2008-02-28 |
| TWI350173B (cg-RX-API-DMAC7.html) | 2011-10-11 |
| AU2005261687B2 (en) | 2011-02-17 |
| HK1103354A1 (en) | 2007-12-21 |
| EP1765388B1 (de) | 2013-04-17 |
| CN101022825B (zh) | 2015-02-04 |
| WO2006005706A8 (de) | 2006-11-16 |
| ES2414872T8 (es) | 2014-11-06 |
| EP1765388A2 (de) | 2007-03-28 |
| CN101022825A (zh) | 2007-08-22 |
| JP5642333B2 (ja) | 2014-12-17 |
| AT500483B1 (de) | 2006-01-15 |
| CA2577332C (en) | 2014-12-09 |
| EP1765388B8 (de) | 2013-05-29 |
| ES2414872T3 (es) | 2013-07-23 |
| AT500483A4 (de) | 2006-01-15 |
| PL1765388T3 (pl) | 2013-09-30 |
| WO2006005706A2 (de) | 2006-01-19 |
| KR101158600B1 (ko) | 2012-07-09 |
| TW200602072A (en) | 2006-01-16 |
| US20110201987A1 (en) | 2011-08-18 |
| US7935348B2 (en) | 2011-05-03 |
| KR20070036158A (ko) | 2007-04-02 |
| JP2013116903A (ja) | 2013-06-13 |
| AU2005261687A1 (en) | 2006-01-19 |
| WO2006005706A3 (de) | 2006-07-20 |
| CA2577332A1 (en) | 2006-01-19 |
| PT1765388E (pt) | 2013-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2005261687B2 (en) | Combination therapy for the prevention or treatment of Alzheimer's disease as well as kit therefor | |
| Marciani | Promising results from Alzheimer’s disease passive immunotherapy support the development of a preventive vaccine | |
| US20230183304A1 (en) | Multi-Epitope Vaccine for the Treatment of Alzheimer's Disease | |
| US20060030027A1 (en) | Capture and removal of biomolecules from body fluids using partial molecular imprints | |
| EA008762B1 (ru) | АНАЛОГ АУТОЛОГИЧНОГО Аβ ИЛИ АРР ЖИВОТНОГО И СПОСОБЫ ЕГО ПРИМЕНЕНИЯ | |
| AU2004271651B2 (en) | Apheresis device | |
| KR20230087495A (ko) | 알츠하이머 질환을 치료하기 위한 β-아밀로이드 백신 | |
| US20230302127A1 (en) | Tau vaccine for the treatment of alzheimer's disease | |
| Li et al. | Enhancing antigen presentation and inducing antigen-specific immune tolerance with amphiphilic peptides | |
| KR102460465B1 (ko) | 알츠하이머병(ad)의 치료 및 예방 | |
| JPH0912462A (ja) | T4リンパ球へのlavウイルス感染を防止する方法 | |
| RU2582389C2 (ru) | ТЕРАПЕВТИЧЕСКОЕ ПРИМЕНЕНИЕ БЕЛКА β2m | |
| HK1103354B (en) | Combination therapy for preventing or treating alzheimer's disease, and kit therefor | |
| WO2013013056A1 (en) | Method for treating amyloid disease | |
| UA60331C2 (uk) | Спосіб лікування розсіяного склерозу | |
| US20250134973A1 (en) | Liposomes Containing Phosphorylated Tau Peptides for Inducing Sustained Immune Responses | |
| Decourtb et al. | Active Immunization Targeting Amyloid β for the Treatment of AlzheimerLs | |
| WO2006097416A1 (en) | Compounds for use in the prevention and treatment of alzheimer's disease | |
| KR20070021102A (ko) | 아페레시스 장치 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| DA3 | Amendments made section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE INVENTION TITLE TO READ COMBINATION THERAPY FOR THE PREVENTION OR TREATMENT OF ALZHEIMER'S DISEASE AS WELL AS KIT THEREFOR |
|
| TH | Corrigenda |
Free format text: IN VOL 25, NO 7, PAGE(S) 815 UNDER THE HEADING APPLICATIONS ACCEPTED - NAME INDEX UNDER THE NAME AFFIRIS FORSCHUNGS-UND ENTWICKLUNGS GMBH, APPLICATION NO.2005261687, UNDER INID (54) CORRECT THE TITLE TO READ COMBINATION THERAPY FOR THE PREVENTION OR TREATMENT OF ALZHEIMER'S DISEASE AS WELL AS KIT THEREFOR |
|
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |